S806 Mirikizumab-Induced Transcriptome Changes in Patient Biopsies at Week 12 Are Maintained Through Week 52 in Patients With Ulcerative Colitis

S806 Mirikizumab-Induced Transcriptome Changes in Patient Biopsies at Week 12 Are Maintained Through Week 52 in Patients With Ulcerative Colitis

Saved in:
Bibliographic Details
Published in:The American journal of gastroenterology Vol. 116; no. 1; pp. S374 - S375
Main Authors: Johnson, Travis, Steere, Boyd, Zhang, Pengyue, Zang, Yong, Higgs, Richard, Gottlieb, Klaus, Reinisch, Walter, Panés, Julian, Krishnan, Venkatesh
Format: Journal Article
Language:English
Published: New York Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins 01-10-2021
Subjects:
Biopsy
Gastroenterology
Gene expression
Inflammatory bowel disease
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0002-9270
1572-0241
DOI:10.14309/01.ajg.0000776756.39821.45